ArticleDiagnostics (Basel, Switzerland)2023
Efficient Skip Connections-Based Residual Network (ESRNet) for Brain Tumor Classification.
Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Deep Learning Approaches for Brain Tumor Detection and Classification Using MRI Images (2020 to 2024): A Systematic Review.Journal of imaging informatics in medicine · 2025Pooled it
- IgeaNet: a deep learning model for opportunistic osteoporosis screening from chest X-ray images.La Radiologia medica · 2026Article
- Artificial Intelligence for the Diagnosis and Management of Cancers: Potentials and Challenges.MedComm · 2025Review
- A multi-modal deep learning solution for precise pneumonia diagnosis: the PneumoFusion-Net model.Frontiers in physiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Brain tumors pose a complex and urgent challenge in medical diagnostics, requiring precise and timely classification due to their diverse characteristics and potentially life-threatening consequences. While existing deep learning (DL)-based brain tumor classification (BTC) models have shown significant progress, they encounter limitations like restricted depth, vanishing gradient issues, and difficulties in capturing intricate features. To address these challenges, this paper proposes an efficient skip connections-based residual network (ESRNet). leveraging the residual network (ResNet) with skip connections. ESRNet ensures smooth gradient flow during training, mitigating the vanishing gradient problem. Additionally, the ESRNet architecture includes multiple stages with increasing numbers of residual blocks for improved feature learning and pattern recognition. ESRNet utilizes residual blocks from the ResNet architecture, featuring skip connections that enable identity mapping. Through direct addition of the input tensor to the convolutional layer output within each block, skip connections preserve the gradient flow. This mechanism prevents vanishing gradients, ensuring effective information propagation across network layers during training. Furthermore, ESRNet integrates efficient downsampling techniques and stabilizing batch normalization layers, which collectively contribute to its robust and reliable performance. Extensive experimental results reveal that ESRNet significantly outperforms other approaches in terms of accuracy, sensitivity, specificity, F-score, and Kappa statistics, with median values of 99.62%, 99.68%, 99.89%, 99.47%, and 99.42%, respectively. Moreover, the achieved minimum performance metrics, including accuracy (99.34%), sensitivity (99.47%), specificity (99.79%), F-score (99.04%), and Kappa statistics (99.21%), underscore the exceptional effectiveness of ESRNet for BTC. Therefore, the proposed ESRNet showcases exceptional performance and efficiency in BTC, holding the potential to revolutionize clinical diagnosis and treatment planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.